StonvexLoading…
StonvexStonvexStonvexCore line items from LAMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.27B | $2.21B | $2.11B | $2.03B |
Operating Income | $774.06M | $532.04M | $675.43M | $578.00M |
Net Income | $587.15M | $361.87M | $495.76M | $438.65M |
EPS (Diluted) | $5.77 | $3.52 | $4.85 | $4.31 |
Total Assets | $6.93B | $6.59B | $6.56B | $6.48B |
Total Liabilities | $5.91B | $5.54B | $5.35B | $5.28B |
Cash & Equivalents | $64.81M | $49.46M | $44.60M | $52.62M |
Free Cash Flow OCF − CapEx | $683.25M | $748.33M | $605.34M | $614.53M |
Shares Outstanding | 101.63M | 102.56M | 102.11M | 101.63M |